More articles from Non-Checkpoint Immunotherapies

Abstract IA23: Microenvironmental regulation of antitumor immune responses: A lesson from fibroblastic cells
Viviana Cremasco, Angelo Grauel, Michael Wu, Jillian Astarita, Matthew Woodruff, Zohreh Amoozgar, Lotte Spel, Flavian Brown, Michael Carroll, Kenzie MacIsaac, Glenn Dranoff, Shannon Turley

Cancer Immunology Research Nov 2016, 4 (11 Supplement) IA23; DOI: 10.1158/2326-6066.IMM2016-IA23
Abstract IA24: New frontiers in oncolytic virus therapy
David M. Reese

Cancer Immunology Research Nov 2016, 4 (11 Supplement) IA24; DOI: 10.1158/2326-6066.IMM2016-IA24
Abstract PR10: Small-molecule inhibitors of CD73 promote activation of human CD8+ T cells and have profound effects on tumor growth and immune parameters in experimental tumors
Juan C. Jaen, Jay P. Powers, Ada Chen, Manmohan R. Leleti, Jarek Kalisiak, Ulrike Schindler, Joanne Bl Tan, Steve Young, Shin-Heng Chiou, Laurent Debien

Cancer Immunology Research Nov 2016, 4 (11 Supplement) PR10; DOI: 10.1158/2326-6066.IMM2016-PR10
Abstract PR11: Neo-antigen landscape dynamics during human melanoma-T cell interactions
Els M.E. Verdegaal, Noel de Miranda, Marten Visser, Tom Harryvan, Marit van Buuren, Rikke Andersen, Sine Hadrup, Caroline van der Minne, Remko Schotte, Hergen Spits, John Haanen, Ellen Kapiteijn, Ton Schumacher, Sjoerd H. Van Der Burg

Cancer Immunology Research Nov 2016, 4 (11 Supplement) PR11; DOI: 10.1158/2326-6066.IMM2016-PR11
Abstract IA25: Synergistic innate and adaptive integrin-targeted immunotherapy
Karl Dane Wittrup

Cancer Immunology Research Nov 2016, 4 (11 Supplement) IA25; DOI: 10.1158/2326-6066.IMM2016-IA25
Abstract B060: Small molecule inhibitors of the anti-inflammatory TAM receptor MerTK
Sacha J. Holland, Alexander M. Owyang, Sylvia Braselmann, Chrystelle Lamagna, Sothy Yi, Chi Young, Roy Frances, Arthur Bagos, Meagan Chan, Ernest Tai, Stacey Siu, Gary Park, David Lau, Matt Duan, Rao Kolluri, Jiaxin Yu, Ihab Darwish, Somasekhar Bhamidipati, Donald G. Payan, Esteban Masuda

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B060; DOI: 10.1158/2326-6066.IMM2016-B060
Abstract B041: Ibrutinib treatment counteracts the immunosuppressive activity of malignant B cells
Meixiao Long, Kyle A. Beckwith, Priscilla Do, Amber Gordon, Amy Lehman, Kami Maddocks, Carolyn Cheney, Jeffrey Jones, Leslie Andritsos, Farrukh Awan, Jennifer Woyach, Johnson J. Amy, Natarajan Muthusamy, John Byrd

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B041; DOI: 10.1158/2326-6066.IMM2016-B041
Abstract B057: The CD122-biased immunostimulatory cytokine NKTR-214 combined with checkpoint blockade leads to mobilization of antitumor immunity and synergistic activity
John L. Langowski, Murali Addepalli, Laurie VanderVeen, Rhoneil Pena, Ravikumar Nutakki, Yolanda Kirksey, Ute Hoch, Jonathan Zalevsky, Stephen K. Doberstein, Deborah H. Charych

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B057; DOI: 10.1158/2326-6066.IMM2016-B057
Abstract B056: Harnessing tissue resident memory T cells to combat solid tumors
Pamela C. Rosato, Luke S. Manlove, Christine E. Nelson, Christopher A. Pennell, Vaiva Vezys, David Masopust

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B056; DOI: 10.1158/2326-6066.IMM2016-B056
Abstract B037: Macrophage repolarization therapy in metastatic colorectal cancer: CCR5 inhibition
Niels Halama, Inka Zoernig, Anna Berthel, Christoph Kahlert, Fee Klupp, Meggy Suarez-Carmona, Juergen Krauss, Karsten Brand, Felix Lasitschka, Tina Lerchl, Claudia Luckner-Minden, Alexis Ulrich, Juergen Weitz, Martin Schneider, Markus W. Buechler, Laurence Zitvogel, Thomas Herrmann, Axel Benner, Christina Kunz, Stephan Luecke, Christoph Springfeld, Christine Falk, Dirk Jaeger

Cancer Immunology Research Nov 2016, 4 (11 Supplement) B037; DOI: 10.1158/2326-6066.IMM2016-B037

Main menu

User menu

Search

More articles from Non-Checkpoint Immunotherapies

Pages

Articles

Info for

About Cancer Immunology Research